- CA$1.73bn
- CA$2.24bn
- CA$807.60m
- 65
- 52
- 99
- 83
Annual income statement for MDA, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 296 | 477 | 641 | 808 |
| Cost of Revenue | ||||
| Gross Profit | 89.1 | 168 | 228 | 244 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 284 | 433 | 573 | 734 |
| Operating Profit | 11.6 | 43.5 | 68.4 | 73.9 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -17.8 | 11.3 | 34.2 | 67.3 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -17.3 | 2.9 | 26.3 | 48.8 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -17.3 | 2.9 | 26.3 | 48.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -17.3 | 2.9 | 26.3 | 48.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.55 | -0.114 | 0.215 | 0.443 |